Simeng Lin

2.2k total citations
25 papers, 168 citations indexed

About

Simeng Lin is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Simeng Lin has authored 25 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 7 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Simeng Lin's work include Inflammatory Bowel Disease (12 papers), Microscopic Colitis (7 papers) and Biosimilars and Bioanalytical Methods (4 papers). Simeng Lin is often cited by papers focused on Inflammatory Bowel Disease (12 papers), Microscopic Colitis (7 papers) and Biosimilars and Bioanalytical Methods (4 papers). Simeng Lin collaborates with scholars based in United Kingdom, United States and Belgium. Simeng Lin's co-authors include Nicholas A. Kennedy, Neil Chanchlani, Matthew Kurien, James Goodhand, Tariq Ahmad, David S. Sanders, Claire Bewshea, David S. Sanders, Imran Aziz and Neel Heerasing and has published in prestigious journals such as Gut, Cell stem cell and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Simeng Lin

22 papers receiving 161 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simeng Lin United Kingdom 8 63 57 50 38 32 25 168
Alexandros Skamnelos Greece 7 91 1.4× 67 1.2× 54 1.1× 24 0.6× 16 0.5× 16 154
Clayton M. Spiceland United States 5 64 1.0× 80 1.4× 70 1.4× 33 0.9× 12 0.4× 7 174
William D. Rawlinson Australia 8 84 1.3× 66 1.2× 61 1.2× 10 0.3× 32 1.0× 9 203
Alejandro Hernández-Camba Spain 7 73 1.2× 57 1.0× 41 0.8× 9 0.2× 19 0.6× 34 147
Haim Leibovitzh Israel 8 60 1.0× 56 1.0× 123 2.5× 47 1.2× 18 0.6× 27 209
Alexander N. Levy United States 6 137 2.2× 116 2.0× 85 1.7× 31 0.8× 59 1.8× 25 241
Kazuhiko Kawakami Japan 7 92 1.5× 73 1.3× 84 1.7× 22 0.6× 33 1.0× 11 220
R K Russell United Kingdom 7 126 2.0× 96 1.7× 52 1.0× 15 0.4× 62 1.9× 19 222
Andrew T. Chan United States 7 126 2.0× 97 1.7× 39 0.8× 24 0.6× 40 1.3× 14 197
Rachel Tayler United Kingdom 7 159 2.5× 89 1.6× 70 1.4× 21 0.6× 60 1.9× 20 283

Countries citing papers authored by Simeng Lin

Since Specialization
Citations

This map shows the geographic impact of Simeng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simeng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simeng Lin more than expected).

Fields of papers citing papers by Simeng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simeng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simeng Lin. The network helps show where Simeng Lin may publish in the future.

Co-authorship network of co-authors of Simeng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Simeng Lin. A scholar is included among the top collaborators of Simeng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simeng Lin. Simeng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dattani, Anish, Simeng Lin, Corin Liddle, et al.. (2024). Naive pluripotent stem cell-based models capture FGF-dependent human hypoblast lineage specification. Cell stem cell. 31(7). 1058–1071.e5. 16 indexed citations
2.
3.
Verstockt, Bram, Valerie Pivorunas, Naim Al Mahi, et al.. (2023). Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn’s Disease in the SERENE Studies. Journal of Crohn s and Colitis. 18(4). 493–505. 3 indexed citations
4.
Lin, Simeng, Eilís Hannon, Mark Reppell, et al.. (2023). Whole Blood DNA Methylation Changes Are Associated with Anti-TNF Drug Concentration in Patients with Crohn’s Disease. Journal of Crohn s and Colitis. 18(8). 1190–1201. 7 indexed citations
5.
Chanchlani, Neil, Simeng Lin, Rachel Nice, et al.. (2023). Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn’s Disease. Crohn s & Colitis 360. 5(3). otad026–otad026. 5 indexed citations
6.
Lin, Simeng, Eilís Hannon, Jeffrey F. Waring, et al.. (2023). DOP88 Understanding the molecular mechanisms of anti-TNF treatment failure: Whole blood DNA methylation changes associated with primary non-response to anti-TNF treatment in patients with Crohn’s disease. Journal of Crohn s and Colitis. 17(Supplement_1). i164–i166. 2 indexed citations
7.
Lin, Simeng, Neil Chanchlani, Callum M. Roberts, et al.. (2023). P662 Pre-treatment vitamin D concentrations do not predict therapeutic outcome to anti-TNF therapies in biologic-naïve patients with active luminal Crohn’s disease. Journal of Crohn s and Colitis. 17(Supplement_1). i791–i793. 1 indexed citations
8.
Chanchlani, Neil, Simeng Lin, Benjamin Hamilton, et al.. (2023). O59 Understanding anti-TNF treatment failure: mechanisms and management of loss of response to anti-TNF therapy, three-year data from the PANTS study. Oral Presentations. A34–A35. 1 indexed citations
9.
Vučković, Frano, Claire Bewshea, Simeng Lin, et al.. (2023). Anti-TNF Biologicals Enhance the Anti-Inflammatory Properties of IgG N-Glycome in Crohn’s Disease. Biomolecules. 13(6). 954–954. 8 indexed citations
10.
Abeysekera, Kushala, et al.. (2022). P303 Exploring attitudes to virtual gastroenterology clinic provision: a patient survey. Poster presentations. A186.1–A186. 1 indexed citations
11.
12.
Lin, Simeng, Louis Ho Shing Lau, Neil Chanchlani, Nicholas A. Kennedy, & Siew C. Ng. (2022). Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic. Gut. 71(7). 1426–1439. 15 indexed citations
13.
Chanchlani, Neil, Simeng Lin, Benjamin Hamilton, et al.. (2021). HMO-4 Immunogenicity to second anti-TNF therapy (IMSAT): implications for sequencing of biologic therapy. A31.2–A32.
14.
15.
Chee, Desmond, Rachel Nice, Benjamin Hamilton, et al.. (2021). Patient-led Remote IntraCapillary pharmacoKinetic Sampling (fingerPRICKS) for Therapeutic Drug Monitoring in patients with Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 16(2). 190–198. 6 indexed citations
16.
Walker, G, Neil Chanchlani, Amanda Thomas, et al.. (2020). Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study. Archives of Disease in Childhood. 105(10). 957–963. 5 indexed citations
17.
Walker, G, Simeng Lin, Neil Chanchlani, et al.. (2020). Quality improvement project identifies factors associated with delay in IBD diagnosis. Alimentary Pharmacology & Therapeutics. 52(3). 471–480. 20 indexed citations
18.
Chee, Desmond, Benjamin Hamilton, Neel Heerasing, et al.. (2020). Root‐cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 53(2). 291–301. 16 indexed citations
19.
Lin, Simeng, et al.. (2015). Long-term outcomes in patients diagnosed with bile-acid diarrhoea. European Journal of Gastroenterology & Hepatology. 28(2). 240–245. 28 indexed citations
20.
Lin, Simeng, Peter D. Mooney, Matthew Kurien, et al.. (2014). Prevalence, investigational pathways and diagnostic outcomes in differing irritable bowel syndrome subtypes. European Journal of Gastroenterology & Hepatology. 26(10). 1176–1180. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandros Skamnelos Breakdown of academic impact, for papers by Clayton M. Spiceland Breakdown of academic impact, for papers by William D. Rawlinson Breakdown of academic impact, for papers by Alejandro Hernández-Camba Breakdown of academic impact, for papers by Haim Leibovitzh Breakdown of academic impact, for papers by Alexander N. Levy Breakdown of academic impact, for papers by Kazuhiko Kawakami Breakdown of academic impact, for papers by R K Russell Breakdown of academic impact, for papers by Andrew T. Chan Breakdown of academic impact, for papers by Rachel Tayler
Rankless by CCL
2026